Radioembolization Planning With Dual-Isotope Acquisition of 166 Ho-Labeled Microparticles and 99m Tc-Mebrofenin

Clin Nucl Med. 2023 Aug 1;48(8):719-721. doi: 10.1097/RLU.0000000000004732. Epub 2023 Jun 8.

Abstract

A 76-year-old man with hepatocellular carcinoma was referred for liver radioembolization. Given a prior left hemihepatectomy, it was clinically important to consider potentially irradiated healthy liver at planning. Thus, at the SPECT/CT imaging of the scout dose 166 Ho-microparticles before injected superselectively in the right hepatic artery, 99m Tc-mebrofenin was injected intravenously, and functional volumetry SPECT was performed simultaneously. Based on the 2 image sets, the nonirradiated healthy liver was calculated as 1589 mL (functional liver reserve of 85.5% on 99m Tc-mebrofenin SPECT). Posttreatment dosimetry calculations showed optimal normal tissue and tumor absorbed doses, and the patient is clinically well after 3 months.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Carcinoma, Hepatocellular* / diagnostic imaging
  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / radiotherapy
  • Embolization, Therapeutic*
  • Humans
  • Isotopes
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / radiotherapy
  • Male
  • Tomography, Emission-Computed, Single-Photon / methods
  • Yttrium Radioisotopes / therapeutic use

Substances

  • mebrofenin
  • Yttrium Radioisotopes
  • Isotopes